Home/Filings/5/0001571049-15-001225
5//SEC Filing

Cyclacel Pharmaceuticals, Inc. 5

Accession 0001571049-15-001225

$BGMSCIK 0001130166operating

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 6:44 PM ET

Size

5.3 KB

Accession

0001571049-15-001225

Insider Transaction Report

Form 5
Period: 2014-12-31
Rombotis Spiro George
DirectorPresident & C.E.O.
Transactions
  • Tax Payment

    Common Stock, $0.001 par value per share

    2014-12-06$2.99/sh3,891$11,634237,525 total
Footnotes (2)
  • [F1]Reduction adjustment to previously reported Restricted Stock Unit award with regard to Federal and state withholding taxes paid by the Company on behalf of the employee.
  • [F2]Of the shares of common stock reported, 142 shares are held indirectly by Mr. Rombotis through his IRA account.

Issuer

Cyclacel Pharmaceuticals, Inc.

CIK 0001130166

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001130166

Filing Metadata

Form type
5
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 6:44 PM ET
Size
5.3 KB